SCHEMBL21775874

SCHEMBL21775874

Cc1cc(N2CCCC(C(=O)O)C2)n2nc(-c3ccc(Cl)cc3)cc2n1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.78
ALDH1A1 P00352 6/20 0.78
HPGD P15428 5/20 0.78
L3MBTL1 Q9Y468 4/20 0.78
HTT P42858 2/20 0.78
SMN1; SMN2 Q16637 2/20 0.78
MAPT P10636 5/20 0.65
HSD17B10 Q99714 4/20 0.65
TP53 P04637 3/20 0.65
ENPP2 Q13822 1/20 0.54
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
LMNA P02545 4/20 0.48
NPSR1 Q6W5P4 4/20 0.48
GLA P06280 2/20 0.48
GAA P10253 2/20 0.48
POLB P06746 2/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21775608 0.85 KDM4E (0.59) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21774124 0.83 KDM4E (0.56) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21775662 0.83 KDM4E (0.56) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21749180 0.83 KDM4E (0.56) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21774146 0.83 KDM4E (0.56) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21774228 0.83 ALDH1A1 (0.61) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21775703 0.82 KDM4E (0.58) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21775583 0.82 KDM4E (0.56) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21774123 0.82 KDM4E (0.56) KDM4EALDH1A1HPGDL3MBTL1HTT
SCHEMBL21775786 0.82 KDM4E (0.56) KDM4EALDH1A1HPGDL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 KDM4E 2972/4885ALDH1A1 585/4885HPGD 1684/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 KDM4E 2972/4885ALDH1A1 585/4885HPGD 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.